HomeTipranavirTipranavir + Omeprazole

Does Tipranavir Interact with Omeprazole?

Tipranavir and Omeprazole have a moderate drug interaction according to U.S. FDA drug labeling data. Probe substrate for CYP2C19; modest inhibition at first dose but marked induction at steady state with APTIVUS/ritonavir; may require monitoring. The mechanism involves cyp2c19 inhibition then induction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Tipranavir Class
Protease Inhibitor
Omeprazole Class
Proton Pump Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Tipranavir and Omeprazole occurs because cyp2c19 inhibition then induction. Clinically, this means probe substrate for cyp2c19; modest inhibition at first dose but marked induction at steady state with aptivus/ritonavir; may require monitoring. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Tipranavir and your doctor is considering prescribing Omeprazole (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tipranavir(Aptivus)+💊 Omeprazole(Yosprala)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Protease Inhibitor
Drug B class
Proton Pump Inhibitor
Source
NLP:tipranavir

What this means in plain English

Probe substrate for CYP2C19; modest inhibition at first dose but marked induction at steady state with APTIVUS/ritonavir; may require monitoring.

About Tipranavir and Omeprazole

Tipranavir is a Protease Inhibitor, while Omeprazole is a Proton Pump Inhibitor. You may recognize them by the brand names Aptivus and Yosprala. Both medications are taken by mouth. Tipranavir additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"CYP2C19 inhibition then induction"

📖 Source: NLP:tipranavir

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Tipranavir and Omeprazole against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.